Endocannabinoid system and phytocannabinoids in the main species of veterinary interest: a comparative review DOI Creative Commons
Alessandra Di Salvo, Elisabetta Chiaradia, Monica Sforna

et al.

Veterinary Research Communications, Journal Year: 2024, Volume and Issue: 48(5), P. 2915 - 2941

Published: Aug. 20, 2024

Since the discovery of endocannabinoid system and due to empirical evidence therapeutic effects on several illnesses both in humans animals that follow administration exogenous cannabinoids (i.e., phytocannabinoids), numerous studies have been conducted. These investigations aimed identify expression distribution cannabinoid receptors healthy pathologic organs tissues different animal species define interactions phytocannabinoids with these receptors. In last decade, pharmacokinetics, efficacy tolerability many Cannabis derivatives formulations, mainly containing cannabidiol, main veterinary interest, also investigated. This manuscript summarizes findings reported by scientific published so far molecular mode action phytocannabinoids, localization tissues, as well dogs, cats, horses other interest. A deep knowledge issues is crucial for use purposes species.

Language: Английский

Pharmacokinetics and tolerability of single-dose enteral cannabidiol and cannabidiolic acid rich hemp in horses (Equus caballus) DOI Creative Commons
Alexander Thomson, Taralyn M. McCarrel,

Alexander Zakharov

et al.

Frontiers in Veterinary Science, Journal Year: 2024, Volume and Issue: 11

Published: April 12, 2024

The pharmacokinetics and tolerability of cannabinoids their metabolites were determined in eight horses after enteral administration a commercial CBD/CBDA-rich hemp oil product. Each horse was administered 2 mg/kg or 8 CBD/CBDA no treatment randomized cross-over design. Serial serum samples collected over 48 h analyzed by high performance liquid chromatography with tandem mass spectrometry. Plasma chemistry analysis performed at 0 24 h. Vital parameters, pedometry, blinded mentation gait evaluations recorded intervals up to Manure production gastrointestinal transit time tracked for administration. median maximal concentration CBD CBDA 5.2 36.95 ng/mL the group, respectively; 40.35 353.56 group. half-life elimination not calculated due lack points above lower quantifiable limit beyond Cmax while it 7.75 absorption biphasic. Pharmacokinetic parameters tetrahydrocannabinol, tetrahydrocannabinolic acid, cannabigerolic 7-carboxy cannabidiol are also reported. No significant differences any measured demonstrated between groups. Single-dose extract does appear produce neurologic, behavioral, effects horses.

Language: Английский

Citations

4

Exploring factors that influence the behavior response to novel object tests in young thoroughbred horses: investigating sex, test site and auction history DOI Creative Commons

Lara Klitzing,

Katharina Kirsch, Maria Schindler

et al.

Frontiers in Veterinary Science, Journal Year: 2025, Volume and Issue: 11

Published: Jan. 15, 2025

The novel object test is one of the three most common fear tests in veterinary science and employed several different species. Although having been applied studies horses, it surprising that there no standardized procedure available for these kinds tests. This study investigated performance on 42 young Thoroughbred horses to determine effect sex (mare or stallion), sites (round pen paddock) whether had previously participated an auction not behavior during test. Differences horses' were primarily attributed sites. animals showed significant (p < 0.05) intra-individual differences round paddock. Sex did affect direct interaction with object. seemed actively perceive more quickly, so latency first fixation was significantly shorter. In order obtain comparable results, recommended should be performed at same location under identical conditions. Furthermore, important consider individual each horse.

Language: Английский

Citations

0

Endocannabinoid system and phytocannabinoids in the main species of veterinary interest: a comparative review DOI Creative Commons
Alessandra Di Salvo, Elisabetta Chiaradia, Monica Sforna

et al.

Veterinary Research Communications, Journal Year: 2024, Volume and Issue: 48(5), P. 2915 - 2941

Published: Aug. 20, 2024

Since the discovery of endocannabinoid system and due to empirical evidence therapeutic effects on several illnesses both in humans animals that follow administration exogenous cannabinoids (i.e., phytocannabinoids), numerous studies have been conducted. These investigations aimed identify expression distribution cannabinoid receptors healthy pathologic organs tissues different animal species define interactions phytocannabinoids with these receptors. In last decade, pharmacokinetics, efficacy tolerability many Cannabis derivatives formulations, mainly containing cannabidiol, main veterinary interest, also investigated. This manuscript summarizes findings reported by scientific published so far molecular mode action phytocannabinoids, localization tissues, as well dogs, cats, horses other interest. A deep knowledge issues is crucial for use purposes species.

Language: Английский

Citations

2